Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
12/2008
12/10/2008CN101318923A Crystalline forms of 'r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-'(phenylamino)carbonyl!-1h-pyrrole-1-heptanoic acid
12/10/2008CN101318922A Novel dipeptidyl peptidase restrainer, synthesizing process and uses thereof
12/10/2008CN100441582C Folid acid derivatives and their salts for preparing antitumor medicine
12/10/2008CN100441569C Novel compounds and compositions containing the same
12/10/2008CN100441568C Aminocyclohexyl ether compounds and uses thereof
12/10/2008CN100441556C Triphenylalkene derivatives and their use as selective estrogen receptor modulators
12/09/2008US7462746 Amino polyols and amino sugars
12/09/2008US7462716 Statin derivatives
12/09/2008US7462689 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents
12/09/2008US7462641 (2S,4S)-4-fluoro-1-[4-fluoro-beta-(4-fluorophenyl)-L-phenylalanyl]-2-pyrrolidinecarbonitrile p-toluenesulfonic acid salt and anhydrous crystalline forms thereof
12/09/2008US7462629 Therapy or prevention diseases caused by lymphocyte interaction; antiinflammatory agents; autoimmune disease
12/09/2008CA2379061C Antibacterial agents
12/09/2008CA2352054C New amidino derivatives and their use as thrombin inhibitors
12/09/2008CA2294059C New amidino derivatives and their use as thrombin inhibitors
12/04/2008WO2008146691A1 Pharmaceutical composition for prevention or treatment of hepatitis
12/04/2008WO2008067863A3 Phenyl substituted maleimides as medicaments for blocking degenerative tissue damages by inhibiting mpt
12/04/2008WO2008002849A3 Aryl sulfones
12/04/2008WO2007127440A3 Heterofunctional poly(ethylene glycol) containing acid-labile amino protecting groups and uses thereof
12/04/2008US20080300413 Efficiently preparing boropyrrolidines and derivatives by coupling a (pyrrolidin3-yl-amino-)acetic acid and a 7,9,8-dioxaborotricyclic- (4,3,0,1(2,4))decane; protecting groups avert side reactions; antidiabetic agents
12/04/2008US20080300348 Polymer
12/04/2008US20080300271 Novel compounds and a novel process for their preparation
12/04/2008US20080300266 metabotropic glutamate receptor (mGluR3) antagonists such as [1-(5-bromopyrimidin-2-yl)-pyrrolidin-3-yl]-(2,4-dichlorobenzyl)-amine, used for the treatment of depression, schizophrenia and headaches
12/04/2008US20080300192 Auristatins Having an Aminobenzoic Acid Unit at the N Terminus
12/04/2008US20080299190 Direct Compression Formulation and Process
12/04/2008US20080299089 Endogeneous repair factor production promoters
12/03/2008EP1997823A1 Boronic ester and acid compounds, synthesis and uses
12/03/2008EP1997803A1 A technique for modification of a bio-product molecule and application of weed control
12/03/2008EP1997495A1 2-phenoxy- and 2-phenylsulfanyl-benzenesulfonamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
12/03/2008EP1997490A1 Oral agent for promoting synthesis of tissue collagen
12/03/2008EP1997489A1 Adamantylglycine derivatives as inhibitors of dipeptidyl peptidase IV for the treatment of diabetes
12/03/2008EP1996547A2 Amine/amide-functionalized lipophiles
12/03/2008EP1996546A2 Substituted gamma lactams as prostaglandin ep2 agonists
12/03/2008EP1996545A1 Soluble epoxide hydrolase inhibitors and methods of using same
12/03/2008EP1996539A2 Method and apparatus for conducting microwave assisted organic reactions with gas-phase reactants
12/03/2008EP1996184A2 Small molecule apoptosis promoters
12/03/2008EP1028961B3 Pleuromutilin derivatives as antimicrobials
12/03/2008CN101316816A Serotonin transporter (SERT) inhibitors
12/03/2008CN101316585A Process for the stereoselective preparation of (-)-halofenate and intermediates thereof
12/03/2008CN100439334C Process for preparing intermediates
12/03/2008CN100439332C Novel thiourea derivatives and the pharmaceutical compositions containing thd same
12/03/2008CN100439330C Aromatic oxyphenyl and aromatic sulfanylphenyl derivatives
12/02/2008US7459585 Benzene derivatives and pharmaceutical use thereof
12/02/2008US7459558 Enzyme inhibitor on NO-synthase enzymes; treating STROKE, NEURODEGENERATIVE DISEASES, preventing ISCHEMIC OR HEMORRAGIC CARDIAC OR CEREBRAL INFARCTIONS; inhibiting lipidic peroxidation
12/02/2008US7459479 Benzylated PDE4 inhibitors
12/02/2008US7459477 Chemical intermediate for agriculture, horticulture compounds; insecticide, fungicides, miticides
12/02/2008US7459473 1-(phenylmethyl)sulfonyl-2-hydroxymethyl pyrrolidine for example; use treating neurological disorders including physically damaged nerves and neurodegenerative diseases; treating alopecia and promoting hair growth
12/02/2008US7459465 Isoquinoline compound and pharmaceutical use thereof
12/02/2008US7459414 Herbicides
12/02/2008CA2424600C Aliphatic nitrogenous five-membered ring compounds
12/02/2008CA2344144C Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
12/02/2008CA2305548C Prostaglandin agonists and their use to treat bone disorders
11/2008
11/27/2008WO2008144748A1 Prolyl endopeptidase inhibitors for reducing or preventing neutrophilic inflammation
11/27/2008WO2008143777A1 Hydroquinone derivative skin brightening compounds
11/27/2008WO2008143342A1 Method for producing 3-amino-2,5-dioxopyrrolidine derivative
11/27/2008WO2008142250A2 Process for preparing porphyrin derivatives, such as protoporphyrin (ix) and synthesis intermediate
11/27/2008WO2008073613A3 Materials and methods for co-crystal controlled solid-state synthesis of imides and imines
11/27/2008WO2008024303A3 Compounds for treating proliferative disorders
11/27/2008WO2007136790A3 Intracellular kinase inhibitors
11/27/2008WO2005025498A3 Substituted acetanilides and benzamides for the treatment of asthma and pulmonary inflammation
11/27/2008US20080293942 Methods of Preparing 2-Imidazol-1-Yl-4-Methyl-6-Pyrrolidin-2-Yl-Pyrimidine and 4-(1-Alkylpyrrolidin-2-Yl)-2-(1H-Imidazol-1-Yl)-6-Methylpyrimidine Derivatives
11/27/2008US20080293920 Arginine Analogs, and Methods for Their Synthesis and Use
11/27/2008US20080293753 Novel Compounds
11/27/2008US20080293727 Amine hydroxyalkyl sulfonamides as enzyme inhibitors; for example, N-1-(3-((3-acetylamino-4-fluoro-benzenesulfonyl)-benzyl-amino)-(1S,2 syn)-1-benzyl-2-hydroxy-propyl)-2-((quinoline-2-carbonyl)-amino)-succinamide; may be used as anti-viral agents against the HIV-1 and HIV-2 viruses
11/27/2008US20080293678 Organic Nitric Oxide Donor Salts of Angiotensin Converting Enzyme Inhibitors, Compositions and Methods of Use
11/27/2008US20080292587 Oximyl dipeptide hepatitis c protease inhibitors
11/27/2008CA2680264A1 Process for preparing porphyrin derivatives, such as protoporphyrin (ix) and synthesis intermediate
11/26/2008EP1995250A1 Ligand, method for producing the same, and catalyst using the ligand
11/26/2008EP1995237A1 Method for producing aminoacetylpyrrolidinecarbonitrile derivative and production intermediate thereof
11/26/2008EP1993998A1 3-carboxy- 2-oxo-1 -pyrrolidine derivatives and their uses
11/26/2008EP1861362B1 Method for preparing enantiomerically pure 4-pyrrolidinophenyl, benzyl, ether derivatives
11/26/2008EP1299110B1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and antimetabolites
11/26/2008CN101313223A Mass labels for biomolecules containing a 2,6-dimethyl-piperidin-l-yl methylene or a pyrimidin-2-yl thiomethylene mass marker moiety and a succinimid-oxy-carbonyl reactive functional group
11/26/2008CN101312948A Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation
11/26/2008CN100436413C Method of separating imide compound
11/25/2008US7456297 crystalline polymorphic dosage forms of anticholesterol agents; statins; small particle size distribution
11/25/2008US7456218 3-(4-{[4'-(benzyloxy)-2',6'-dimethylbiphenyl-3-yl]methoxy}-2-fluorophenyl)propanoic acid; superior GPR40 receptor function modulating action, can be used as an insulin secretagogue, an agent for the prophylaxis or treatment of diabetes
11/25/2008US7456211 Enzyme inhibitors as bactericides for infections and as enzyme inhibitors
11/25/2008US7456210 Benzyloxy derivatives
11/25/2008US7456203 for treatment/prevention of chronic obstructive pulmonary disease, chronic bronchitis, irritable bowel syndrome, and urinary incontinence
11/25/2008US7456202 Marked maleimide compounds, method for preparing same and use thereof for marking macromolecules
11/25/2008US7456196 Alzheimer's disease; antihistamine; attention deficit disorder; hyperactivity; bipolar disorder; cognition activators; psychological disorder; anticancer agent; antidepressants; antiepileptic agents; gastrointestinal disorder; analgesics; 6-{2-[(2R)-2-methyl-1-pyrrolidinyl]ethyl}-2-(3-pyridinyl)quinoline
11/25/2008US7456190 autoimmune disease; antiinflammatory agents; bone disorders; central nervous system disorders; cardiovascular disorders; Alzheimer's disease; antihistamines; antiallergens
11/25/2008US7455827 Process for preparing a catalyst for conversion of cyanopyridines to nicotinamides
11/24/2008CA2631978A1 Adhesive formulations
11/20/2008WO2008140251A2 Cyclooxygenase-2 inhibitors
11/20/2008WO2008138551A2 3-(2-alkoxy-phenyl)-substituted tetramates
11/20/2008WO2008100651A3 Preparation of darifenacin and its salts
11/20/2008US20080288176 Development of Prodrugs Possessing a Nitric Oxide Donor Diazen-1-Ium-1,2-Diolate Noiety Using in Vitro/in Silico Predictions
11/20/2008US20080287691 Polymorphic form of atorvastatin calcium
11/20/2008US20080287690 Process For (3R, 5R)-7-[2-(4-Fluorophenyl)-5-Isopropyl-3-Phenyl-4- [(4-Hydroxy Methyl Phenyl Amino) Carbonyl]-Pyrrol-1-Yl]-3,5-Dihydroxy-Heptanoic Acid Hemi Calcium Salt
11/20/2008US20080287687 Production method of diphenylalanine-Ni (II) complex
11/20/2008US20080287674 Inhibitors of Factor XA and Other Serine Proteases Involved in the Coagulation Cascade
11/20/2008US20080287523 Pyrrolidin-3-Yl Compounds Useful as Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
11/20/2008US20080287522 reduced or no emetogenic effects ; benzylated phosphodiesterase 4 inhibitors; e.g. Rolipram, Ariflo, Arofylline; preparation by benzylation using benzyl bromide or a derivative; antiinflammatory agents; to treat autoimmune diseases; cystic fibrosis
11/20/2008US20080287521 Crystalline Forms Of [R-(R*,R*)-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methyl- Ethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid Calcium Salt (2:1)
11/20/2008US20080287516 Phenyl-Substituted Pyrrolidones
11/20/2008US20080287506 Insecticidal N,N-Di(Heteroarylalkyl) Amine Derivatives
11/20/2008US20080287449 Aza-tripeptide hepatitis c serine protease inhibitors
11/20/2008US20080287442 Organic Compounds
11/20/2008US20080287435 Active Ingredient Combinations Having Insecticide and Acaricide Properties
1 ... 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 ... 404